全文获取类型
收费全文 | 2580455篇 |
免费 | 189261篇 |
国内免费 | 7552篇 |
专业分类
耳鼻咽喉 | 34264篇 |
儿科学 | 85156篇 |
妇产科学 | 71563篇 |
基础医学 | 363467篇 |
口腔科学 | 69644篇 |
临床医学 | 234138篇 |
内科学 | 514499篇 |
皮肤病学 | 62446篇 |
神经病学 | 213323篇 |
特种医学 | 99851篇 |
外国民族医学 | 736篇 |
外科学 | 386267篇 |
综合类 | 50335篇 |
现状与发展 | 5篇 |
一般理论 | 968篇 |
预防医学 | 195726篇 |
眼科学 | 56582篇 |
药学 | 187903篇 |
8篇 | |
中国医学 | 5331篇 |
肿瘤学 | 145056篇 |
出版年
2021年 | 19988篇 |
2019年 | 20624篇 |
2018年 | 29279篇 |
2017年 | 22590篇 |
2016年 | 26224篇 |
2015年 | 29501篇 |
2014年 | 40443篇 |
2013年 | 60432篇 |
2012年 | 80241篇 |
2011年 | 84502篇 |
2010年 | 51013篇 |
2009年 | 49150篇 |
2008年 | 79032篇 |
2007年 | 83850篇 |
2006年 | 85583篇 |
2005年 | 81737篇 |
2004年 | 78736篇 |
2003年 | 76051篇 |
2002年 | 73337篇 |
2001年 | 128413篇 |
2000年 | 131342篇 |
1999年 | 110508篇 |
1998年 | 31263篇 |
1997年 | 27921篇 |
1996年 | 28221篇 |
1995年 | 27385篇 |
1994年 | 25069篇 |
1993年 | 23419篇 |
1992年 | 85164篇 |
1991年 | 81570篇 |
1990年 | 78788篇 |
1989年 | 76067篇 |
1988年 | 69476篇 |
1987年 | 68000篇 |
1986年 | 63545篇 |
1985年 | 60521篇 |
1984年 | 44946篇 |
1983年 | 37950篇 |
1982年 | 22460篇 |
1981年 | 19986篇 |
1979年 | 38962篇 |
1978年 | 27440篇 |
1977年 | 23255篇 |
1976年 | 21495篇 |
1975年 | 22815篇 |
1974年 | 26790篇 |
1973年 | 25371篇 |
1972年 | 23755篇 |
1971年 | 21959篇 |
1970年 | 20167篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
161.
Feasibility and Diagnostic Potential of Pulmonary Transit Time Measurement by Contrast Echocardiography: A Pilot Study 下载免费PDF全文
162.
E. M. Peterman C. Sullivan M. F. Goody I. Rodriguez-Nunez J. A. Yoder C. H. Kim 《Infection and immunity》2015,83(1):430-440
Mitochondria are known primarily as the location of the electron transport chain and energy production in cells. More recently, mitochondria have been shown to be signaling centers for apoptosis and inflammation. Reactive oxygen species (ROS) generated as by-products of the electron transport chain within mitochondria significantly impact cellular signaling pathways. Because of the toxic nature of ROS, mitochondria possess an antioxidant enzyme, superoxide dismutase 2 (SOD2), to neutralize ROS. If mitochondrial antioxidant enzymes are overwhelmed during severe infections, mitochondrial dysfunction can occur and lead to multiorgan failure or death. Pseudomonas aeruginosa is an opportunistic pathogen that can infect immunocompromised patients. Infochemicals and exotoxins associated with P. aeruginosa are capable of causing mitochondrial dysfunction. In this work, we describe the roles of SOD2 and mitochondrial ROS regulation in the zebrafish innate immune response to P. aeruginosa infection. sod2 is upregulated in mammalian macrophages and neutrophils in response to lipopolysaccharide in vitro, and sod2 knockdown in zebrafish results in an increased bacterial burden. Further investigation revealed that phagocyte numbers are compromised in Sod2-deficient zebrafish. Addition of the mitochondrion-targeted ROS-scavenging chemical MitoTEMPO rescues neutrophil numbers and reduces the bacterial burden in Sod2-deficient zebrafish. Our work highlights the importance of mitochondrial ROS regulation by SOD2 in the context of innate immunity and supports the use of mitochondrion-targeted ROS scavengers as potential adjuvant therapies during severe infections. 相似文献
163.
Pancreatic ductal adenocarcinoma (PDAC) is predicted to become the second leading cause of cancer-related mortality within the next decade, with limited effective treatment options and a dismal long-term prognosis for patients. Genomic profiling has not yet manifested clinical benefits for diagnosis, treatment or prognosis in PDAC, due to the lack of available tissues for sequencing and the confounding effects of low tumour cellularity in many biopsy specimens. Increasing focus is now turning to the use of minimally invasive liquid biopsies to enhance the characterisation of actionable PDAC tumour genomes. Circulating tumour DNA (ctDNA) is the most comprehensively studied liquid biopsy analyte in blood and can provide insight into the molecular profile and biological characteristics of individual PDAC tumours, in real-time and in advance of traditional imaging modalities. This can pave the way for identification of new therapeutic targets, novel risk variants and markers of tumour response, to supplement diagnostic screening and provide enhanced scrutiny in treatment stratification. In the roadmap towards the application of precision medicine for clinical management in PDAC, ctDNA analyses may serve a leading role in streamlining candidate biomarkers for clinical integration. In this review, we highlight recent developments in the use of ctDNA-based liquid biopsies for PDAC and provide new insights into the technical, analytical and biological challenges that must be overcome for this potential to be realised. 相似文献
164.
165.
166.
167.
168.
169.
170.